Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anca Gal-Moscovici"'
Publikováno v:
Artificial Organs. 38:474-483
The accumulation of advanced glycation end products (AGEs) has been reported to be a major contributor to chronic systemic inflammation. AGEs are not efficiently removed by hemodialysis or the kidney of a chronic kidney disease (CKD) patient. The goa
Autor:
Nalini M. Rajamannan, Abraham Nyska, Suzan Abedat, Ronen Beeri, Mony Shuvy, Anca Gal-Moscovici, Chaim Lotan
Publikováno v:
Experimental and Toxicologic Pathology. 63:303-306
High adenine phosphate (HAP) diet serves as an animal model of chronic renal failure (RF). Induction of RF and establishment of end organ damage require long exposure periods to this diet. Previously, we have shown that RF is reversible after diet ce
Autor:
Ronen Levy, Anca Gal-Moscovici
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 28:11-19
Bone disease is one of the most challenging complications in patients with chronic kidney disease. Today, it is considered to be part of a complex systemic disorder manifested by disturbances of mineral metabolism and vascular calcifications called c
Publikováno v:
Clinical Reviews in Bone and Mineral Metabolism. 5:27-38
Chronic kidney disease (CKD) is accompanied by disturbances in calcium, phosphate, vitamin D, and parathyroid hormone (PTH) homeostasis known to play an important role in the pathophysiology of renal osteodystrophy. Increased cardiovascular morbidity
Autor:
Stuart M. Sprague, Anca Gal-Moscovici
Publikováno v:
Seminars in Dialysis. 20:423-430
Osteoporosis (OP), the most frequent bone disease affecting the general population, is associated with high fracture risk. Patients with impaired kidney function have bone and mineral disturbances leading to extraskeletal calcifications and complex c
Autor:
Anca Gal-Moscovici, Stuart M. Sprague
Publikováno v:
Clinical Drug Investigation. 27:105-113
Background and objective: Substantial data for the relative costs of hospitalisation in paricalcitol and calcitriol-treated patients with chronic kidney disease stage 4 do not exist. The objective of this study was to compare the cost benefit of pari
Publikováno v:
Physiological Reports
Aging is associated with alteration in renal tubular functions, including sodium handling and concentrating ability. Na-K-ATPase plays a key role in driving tubular transport, and we hypothesized that decreased concentrating ability of the aging kidn
Autor:
Stuart M. Sprague, Anca Gal-Moscovici
Publikováno v:
Kidney International. 70:S68-S72
Secondary hyperparathyroidism (SHPT) develops in chronic kidney disease as a consequence of impaired phosphate, calcium, and vitamin D homeostasis. Treatment strategies directed to reduce the parathyroid hormone (PTH) concentrations have included pho
Publikováno v:
Nephrology Dialysis Transplantation. 17:620-624
Background. Osteitis fibrosa cystica (OFC) caused by secondary hyperparathyroidism is the pre-eminent form of uraemic osteodystrophy. In recent years, however, new bone abnormalities have been described. Amongthemadynamicbonedisease(ABD)hasbecome a f
Autor:
Nirav Shah, Stuart M. Sprague, John Cunningham, Beth Piraino, Anca Gal-Moscovici, Alastair J. Hutchison
Publikováno v:
Seminars in Dialysis. 20:24-26
The K-DOQI guidelines for bone metabolism in chronic kidney disease recommend measuring 25(OH) vitamin D levels and correcting deficiencies in stages 3 and 4 but not in ESRD. Most nephrologists are not concerned with 25(OH) vitamin D deficiency, desp